|
26 Companies |
|
51 Products |
|
51 Products |
|
56 Mechanisms of Action |
|
3 Trials |
|
839 News |
|
| 12345678910111213...1617» |
- | Trial termination: HyTe-2: Glucose Metabolism Disorders and Metabolic Syndrome Before and After Primary Hip and Knee Replacement (clinicaltrials.gov) - Oct 18, 2023
P=N/A, N=155, Terminated, Sponsor: Coxa, Hospital for Joint Replacement
Suspended --> Terminated; Primary researcher not able to continue research at the moment.
- | NN1213 / Novo Nordisk
Trial completion: A Short Term Evaluation of a Structured Weight Loss Plan in Overweight and Obese Adults (clinicaltrials.gov) - Mar 30, 2023
P=N/A, N=20, Completed, Sponsor: University of Missouri-Columbia
Suspended --> Terminated; Primary researcher not able to continue research at the moment. Withdrawn --> Completed
- | Trial completion, Trial completion date, Trial primary completion date: Exploring the Role of Adipocyte Fatty Acid Binding Protein in the Association of Obstructive Sleep Apnea and Metabolic Dysfunction (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=90, Completed, Sponsor: The University of Hong Kong
Withdrawn --> Completed Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Dec 2018 | Trial primary completion date: Jun 2018 --> Dec 2018
- | Enrollment change, Trial withdrawal, Surgery: Prospective Cohort Study for Analyzing the Effect of Gastric Cancer Surgery to the Metabolic Syndrome and Insulin Resistance (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=0, Withdrawn, Sponsor: Yonsei University
Active, not recruiting --> Completed | Trial completion date: Jun 2018 --> Dec 2018 | Trial primary completion date: Jun 2018 --> Dec 2018 N=270 --> 0 | Recruiting --> Withdrawn
- | NN1213 / Novo Nordisk
Trial completion, Phase classification, Enrollment change, Trial completion date, Trial primary completion date: Resveratrol in Metabolic Syndrome: Effect on Platelet Hyper-reactivity and HDL Lipid Peroxidation (clinicaltrials.gov) - Apr 19, 2019
P=N/A, N=41, Completed, Sponsor: Vanderbilt University
N=270 --> 0 | Recruiting --> Withdrawn Enrolling by invitation --> Completed | Phase classification: P3 --> PN/A | N=118 --> 41 | Trial completion date: Dec 2018 --> Apr 2019 | Trial primary completion date: Jul 2018 --> Feb 2019
- | rosuvastatin/telmisartan / Generic mfg.
Enrollment change, Trial termination: A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome (clinicaltrials.gov) - Apr 12, 2019
P4, N=55, Terminated, Sponsor: Yuhan Corporation
Enrolling by invitation --> Completed | Phase classification: P3 --> PN/A | N=118 --> 41 | Trial completion date: Dec 2018 --> Apr 2019 | Trial primary completion date: Jul 2018 --> Feb 2019 N=204 --> 55 | Recruiting --> Terminated; Due to poor enrollment rate
- | Trial completion: OLNAMS: Olive Oil and Nampt on Postprandial Inflammation and Atherosclerosis in the Setting of Metabolic Syndrome (clinicaltrials.gov) - Mar 13, 2019
P=N/A, N=40, Completed, Sponsor: National Research Council, Spain
N=204 --> 55 | Recruiting --> Terminated; Due to poor enrollment rate Active, not recruiting --> Completed
- ||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Cross-Sectional Iloperidone IVGTT (clinicaltrials.gov) - Mar 12, 2019
P=N/A, N=37, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed Recruiting --> Completed | N=60 --> 37 | Trial completion date: Dec 2015 --> May 2016 | Trial primary completion date: Dec 2015 --> May 2016
- | Trial completion, Enrollment change, Trial completion date: Normobaric Hypoxic Training and Metabolic Syndrome (clinicaltrials.gov) - Mar 4, 2019
P=N/A, N=27, Completed, Sponsor: Charite University, Berlin, Germany
Recruiting --> Completed | N=60 --> 37 | Trial completion date: Dec 2015 --> May 2016 | Trial primary completion date: Dec 2015 --> May 2016 Active, not recruiting --> Completed | N=40 --> 27 | Trial completion date: Mar 2018 --> Jun 2018
- | Biomarker, Trial completion: MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome (clinicaltrials.gov) - Feb 27, 2019
P=N/A, N=55, Completed, Sponsor: Holbaek Sygehus
Active, not recruiting --> Completed | N=40 --> 27 | Trial completion date: Mar 2018 --> Jun 2018 Recruiting --> Completed
- | Trial completion: Effect of Dietary Macronutrient Composition (clinicaltrials.gov) - Feb 6, 2019
P=N/A, N=24, Completed, Sponsor: University of Texas Southwestern Medical Center
Recruiting --> Completed Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Seum Bile Acid Profile in Type 2 Diabetes and Association Between Bile Cid Profile and Adipokine or Oxidative Stress (clinicaltrials.gov) - Jan 22, 2019
P=N/A, N=362, Completed, Sponsor: Yonsei University
Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Dec 2016 --> Jul 2018 | Trial primary completion date: Dec 2016 --> Jul 2018
- | dobutamine / Generic mfg.
Trial completion, Trial primary completion date: Myocardial Regional Function by Dobutamine Stress Echocardiography in the Metabolic Syndrome and Type 2 Diabetes (clinicaltrials.gov) - Jan 18, 2019
P=N/A, N=125, Completed, Sponsor: University of Avignon
Recruiting --> Completed | Trial completion date: Dec 2016 --> Jul 2018 | Trial primary completion date: Dec 2016 --> Jul 2018 Recruiting --> Completed | Trial primary completion date: Dec 2018 --> Jan 2018
- | valsartan / Generic mfg.
Enrollment change, Trial withdrawal: Regression of Fatty Heart by Valsartan Therapy (clinicaltrials.gov) - Jan 17, 2019
P4, N=0, Withdrawn, Sponsor: University of Texas Southwestern Medical Center
Recruiting --> Completed | Trial primary completion date: Dec 2018 --> Jan 2018 N=28 --> 0 | Recruiting --> Withdrawn
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Stress and Sugar Synergy (clinicaltrials.gov) - Jan 16, 2019
P=N/A, N=23, Completed, Sponsor: University of California, Davis
N=28 --> 0 | Recruiting --> Withdrawn Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Dec 2016 | Trial primary completion date: Dec 2018 --> Dec 2016
- | NN1213 / Novo Nordisk
Trial completion: The Impact of Low-fat and Full-fat Dairy Consumption on Glucose Homeostasis (DAIRY Study) (clinicaltrials.gov) - Jan 16, 2019
P=N/A, N=72, Completed, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed | Trial completion date: Dec 2018 --> Dec 2016 | Trial primary completion date: Dec 2018 --> Dec 2016 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial primary completion date: Phospholipid and Sphingolipid Composition of High-density Lipoproteins (HDL) in Obese Non-diabetic Patients With Metabolic Syndrome (clinicaltrials.gov) - Jan 10, 2019
P=N/A, N=89, Completed, Sponsor: Centre Hospitalier Universitaire Dijon
Active, not recruiting --> Completed Trial primary completion date: Nov 2015 --> Nov 2016
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial initiation date, Trial primary completion date: Effects of Prehabilitation in Gastric Cancer Patients With Metabolic Syndrome on Perioperative Outcome (clinicaltrials.gov) - Dec 20, 2018
P=N/A, N=82, Completed, Sponsor: Qingdao University
Trial primary completion date: Nov 2015 --> Nov 2016 Recruiting --> Completed | N=54 --> 82 | Trial completion date: Dec 2016 --> Feb 2018 | Initiation date: Dec 2015 --> Sep 2015 | Trial primary completion date: Dec 2016 --> Feb 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD (clinicaltrials.gov) - Dec 11, 2018
P1/2, N=21, Completed, Sponsor: Lawson Health Research Institute
Recruiting --> Completed | N=54 --> 82 | Trial completion date: Dec 2016 --> Feb 2018 | Initiation date: Dec 2015 --> Sep 2015 | Trial primary completion date: Dec 2016 --> Feb 2018 Active, not recruiting --> Completed | Trial completion date: Sep 2018 --> Dec 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date: EFIGRO: Effect of Exercise on Hepatic Fat in Overweight Children (clinicaltrials.gov) - Nov 15, 2018
P=N/A, N=115, Completed, Sponsor: Basque Country University
Active, not recruiting --> Completed | Trial completion date: Sep 2018 --> Dec 2018 Recruiting --> Completed | Trial completion date: Jun 2018 --> Jan 2018
- | NN1213 / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: Endogenous Opioid Activity and Affective State in Insulin Resistant Women (clinicaltrials.gov) - Nov 8, 2018
P4, N=42, Completed, Sponsor: University of Michigan
Recruiting --> Completed | Trial completion date: Jun 2018 --> Jan 2018 Active, not recruiting --> Completed | Trial completion date: Dec 2022 --> Sep 2017 | Trial primary completion date: Dec 2019 --> Mar 2017
- | NN1213 / Novo Nordisk
Enrollment change, Trial termination: Aldosterone Antagonism and Microvascular Function (clinicaltrials.gov) - Nov 5, 2018
P4, N=25, Terminated, Sponsor: Maastricht University Medical Center
Active, not recruiting --> Completed | Trial completion date: Dec 2022 --> Sep 2017 | Trial primary completion date: Dec 2019 --> Mar 2017 N=60 --> 25 | Recruiting --> Terminated; Failure to recruit sufficient participants
- | Trial completion: Women's Lifestyle Balance Study (clinicaltrials.gov) - Oct 25, 2018
P=N/A, N=26, Completed, Sponsor: University of California, San Francisco
N=60 --> 25 | Recruiting --> Terminated; Failure to recruit sufficient participants Active, not recruiting --> Completed
- | Trial completion, Phase classification, Trial completion date: Resveratrol and the Metabolic Syndrome (clinicaltrials.gov) - Oct 24, 2018
P=N/A, N=28, Completed, Sponsor: Rockefeller University
Active, not recruiting --> Completed Active, not recruiting --> Completed | Phase classification: P2 --> PN/A | Trial completion date: Dec 2018 --> Jul 2018
- | NN1213 / Novo Nordisk
Trial completion: HEPAFIT: Exercise Training and Hepatic Metabolism in Overweight/Obese Adolescent (clinicaltrials.gov) - Oct 11, 2018
P=N/A, N=120, Completed, Sponsor: Universidad Santo Tomas
Active, not recruiting --> Completed | Phase classification: P2 --> PN/A | Trial completion date: Dec 2018 --> Jul 2018 Not yet recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial primary completion date: Aldosterone Antagonism and Microvascular Function (clinicaltrials.gov) - Oct 11, 2018
P4, N=60, Recruiting, Sponsor: Maastricht University Medical Center
Not yet recruiting --> Completed Trial primary completion date: Jun 2018 --> Nov 2018
- | NN1213 / Novo Nordisk
Trial completion: Effects of TA-65, a Telomerase Activator on Metabolic Syndrome (clinicaltrials.gov) - Oct 10, 2018
P=N/A, N=40, Completed, Sponsor: University of Connecticut
Trial primary completion date: Jun 2018 --> Nov 2018 Active, not recruiting --> Completed
- | Trial completion, Trial completion date: The Effect of Sitting and Moderate Exercise on Plasma Triglyceride Elevation After a Meal (clinicaltrials.gov) - Oct 5, 2018
P=N/A, N=10, Completed, Sponsor: University of Texas at Austin
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Feb 2018 --> Aug 2017
- | Trial completion, Trial completion date: The Effects of Prolonged Standing Compared to Prolonged Sitting on Postprandial Lipemia (clinicaltrials.gov) - Oct 4, 2018
P=N/A, N=12, Completed, Sponsor: University of Texas at Austin
Active, not recruiting --> Completed | Trial completion date: Feb 2018 --> Aug 2017 Active, not recruiting --> Completed | Trial completion date: Feb 2018 --> Aug 2018
- | Trial completion, Phase classification, Enrollment change, Trial completion date, Trial primary completion date: Dietetic and Hygiene Measures in Metabolic Neuropathies: the Neurodiet Study (clinicaltrials.gov) - Aug 29, 2018
P3, N=8, Completed, Sponsor: Henri Mondor University Hospital
Active, not recruiting --> Completed | Trial completion date: Feb 2018 --> Aug 2018 Recruiting --> Completed | Phase classification: PN/A --> P3 | N=40 --> 8 | Trial completion date: Nov 2016 --> Jun 2018 | Trial primary completion date: Nov 2016 --> Jun 2018
- | NN1213 / Novo Nordisk
Biomarker, Trial completion, Trial completion date, Trial primary completion date: NUTREND: Development of Endothelial Biomarkers (clinicaltrials.gov) - Aug 28, 2018
P=N/A, N=60, Completed, Sponsor: University Hospital, Clermont-Ferrand
Recruiting --> Completed | Phase classification: PN/A --> P3 | N=40 --> 8 | Trial completion date: Nov 2016 --> Jun 2018 | Trial primary completion date: Nov 2016 --> Jun 2018 Recruiting --> Completed | Trial completion date: Oct 2016 --> Sep 2017 | Trial primary completion date: Aug 2016 --> Dec 2016
- | NN1213 / Novo Nordisk
Enrollment closed, Phase classification, Trial completion date, Trial primary completion date: Effect of Implantable Contraception on Type-2 DM and Metabolic Syndrome in Women With History of Gestational DM (clinicaltrials.gov) - Aug 22, 2018
P=N/A, N=260, Active, not recruiting, Sponsor: Mahidol University
Recruiting --> Completed | Trial completion date: Oct 2016 --> Sep 2017 | Trial primary completion date: Aug 2016 --> Dec 2016 Recruiting --> Active, not recruiting | Phase classification: P2 --> PN/A | Trial completion date: Mar 2016 --> Jun 2022 | Trial primary completion date: Mar 2016 --> Mar 2017
- | NN1213 / Novo Nordisk
Trial completion: Acupuncture in the Regulation of Dai Meridian for the Metabolism of Visceral Adipose Tissue in Abdominal Obese Patients (clinicaltrials.gov) - Aug 17, 2018
P=N/A, N=120, Completed, Sponsor: Dongfang Hospital Affiliated to Beijing University of Chinese Medicine
Recruiting --> Active, not recruiting | Phase classification: P2 --> PN/A | Trial completion date: Mar 2016 --> Jun 2022 | Trial primary completion date: Mar 2016 --> Mar 2017 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Enrollment closed: The Impact of Low-fat and Full-fat Dairy Consumption on Glucose Homeostasis (DAIRY Study) (clinicaltrials.gov) - Aug 13, 2018
P=N/A, N=72, Active, not recruiting, Sponsor: Fred Hutchinson Cancer Research Center
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- | Trial completion date: HyTe-2: Glucose Metabolism Disorders and Metabolic Syndrome Before and After Primary Hip and Knee Replacement (clinicaltrials.gov) - Jul 20, 2018
P=N/A, N=155, Suspended, Sponsor: Coxa, Hospital for Joint Replacement
Recruiting --> Active, not recruiting Trial completion date: Jun 2018 --> Jun 2019
- | NN1213 / Novo Nordisk
Trial completion: Impact of a Nutritional Intervention on Type1 Diabetes Adult With Metabolic Syndrome (clinicaltrials.gov) - Jul 19, 2018
P=N/A, N=29, Completed, Sponsor: Institut de Recherches Cliniques de Montreal
Trial completion date: Jun 2018 --> Jun 2019 Active, not recruiting --> Completed
- | Trial completion: Effect of Vegetable Oils for Use by the Snack Food Industry on Plasma Lipid Levels and Inflammatory Markers (clinicaltrials.gov) - Jul 13, 2018
P=N/A, N=30, Completed, Sponsor: Tufts University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Viracept (nelfinavir) / ViiV Healthcare, Roche, NN1213 / Novo Nordisk
Trial completion: METALIP: Prevalence of Lipodystrophy Syndrome and Its Role as Cause of Metabolic Disturbances (clinicaltrials.gov) - Jul 2, 2018
P=N/A, N=276, Completed, Sponsor: Asociacion para el Estudio de las Enfermedades Infecciosas
Active, not recruiting --> Completed Recruiting --> Completed
- | Phase classification: A Study of the Function of Hormones Present In Taste Buds (clinicaltrials.gov) - Apr 6, 2018
P, N=225, Completed, Sponsor: National Institute on Aging (NIA)
Recruiting --> Completed Phase classification: P=N/A --> P
- | Enrollment change, Trial withdrawal: A Short Term Evaluation of a Structured Weight Loss Plan in Overweight and Obese Adults (clinicaltrials.gov) - Apr 4, 2018
P=N/A, N=0, Withdrawn, Sponsor: University of Missouri-Columbia
Phase classification: P=N/A --> P N=20 --> 0 | Active, not recruiting --> Withdrawn
- | Trial completion date: Resveratrol and the Metabolic Syndrome (clinicaltrials.gov) - Apr 2, 2018
P2, N=28, Active, not recruiting, Sponsor: Rockefeller University
N=20 --> 0 | Active, not recruiting --> Withdrawn Trial completion date: Dec 2017 --> Dec 2018
- | Trial completion, Trial primary completion date: Effects of a Standardized Freeze-dried Grape Powder on High Density Lipoprotein (HDL) Function in Metabolic Syndrome (clinicaltrials.gov) - Mar 23, 2018
P=N/A, N=20, Completed, Sponsor: University of Connecticut
Trial completion date: Dec 2017 --> Dec 2018 Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Mar 2018
- | Trial primary completion date: Resveratrol in Metabolic Syndrome: Effect on Platelet Hyper-reactivity and HDL Lipid Peroxidation (clinicaltrials.gov) - Mar 21, 2018
P3, N=118, Enrolling by invitation, Sponsor: Vanderbilt University
Active, not recruiting --> Completed | Trial primary completion date: Dec 2017 --> Mar 2018 Trial primary completion date: Dec 2017 --> Jul 2018
- |||| Victoza (liraglutide) / Novo Nordisk
Trial completion, Trial completion date, Trial primary completion date: MAGNA VICTORIA: Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent (clinicaltrials.gov) - Mar 21, 2018
P4, N=51, Completed, Sponsor: Leiden University Medical Center
Trial primary completion date: Dec 2017 --> Jul 2018 Active, not recruiting --> Completed | Trial completion date: Sep 2018 --> Mar 2018 | Trial primary completion date: Sep 2018 --> Mar 2018
- | Trial completion: Metasperme: Metabolic Syndrome and Male Infertility (clinicaltrials.gov) - Mar 19, 2018
P=N/A, N=170, Completed, Sponsor: Assistance Publique - H
Active, not recruiting --> Completed | Trial completion date: Sep 2018 --> Mar 2018 | Trial primary completion date: Sep 2018 --> Mar 2018 Active, not recruiting --> Completed
- | ethinyl estradiol/norgestimate / Generic mfg.
Trial completion date: Oral Contraceptives in the Metabolic Syndrome (clinicaltrials.gov) - Mar 12, 2018
P4, N=36, Active, not recruiting, Sponsor: Virginia Commonwealth University
Active, not recruiting --> Completed Trial completion date: Dec 2017 --> Apr 2018
- | Trial completion, Trial primary completion date: Oral Nitrite in Adults With Metabolic Syndrome and Hypertension (clinicaltrials.gov) - Mar 7, 2018
P2, N=20, Completed, Sponsor: University of Pittsburgh
Trial completion date: Dec 2017 --> Apr 2018 Recruiting --> Completed | Trial primary completion date: Dec 2017 --> Feb 2018
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: China Action on Spine and Hip Status (clinicaltrials.gov) - Mar 6, 2018
P=N/A, N=3457, Completed, Sponsor: Beijing Jishuitan Hospital
Recruiting --> Completed | Trial primary completion date: Dec 2017 --> Feb 2018 Recruiting --> Completed | N=5000 --> 3457 | Trial completion date: Dec 2017 --> Jul 2017 | Trial primary completion date: Jun 2017 --> Jul 2017
- | dobutamine / Generic mfg.
Trial completion date, Trial primary completion date: Myocardial Regional Function by Dobutamine Stress Echocardiography in the Metabolic Syndrome and Type 2 Diabetes (clinicaltrials.gov) - Mar 6, 2018
P=N/A, N=102, Recruiting, Sponsor: University of Avignon
Recruiting --> Completed | N=5000 --> 3457 | Trial completion date: Dec 2017 --> Jul 2017 | Trial primary completion date: Jun 2017 --> Jul 2017 Trial completion date: Feb 2018 --> Jan 2019 | Trial primary completion date: Feb 2018 --> Dec 2018
- | Enrollment closed, Trial completion date, Trial primary completion date: Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD (clinicaltrials.gov) - Mar 6, 2018
P1/2, N=21, Active, not recruiting, Sponsor: Lawson Health Research Institute
Trial completion date: Feb 2018 --> Jan 2019 | Trial primary completion date: Feb 2018 --> Dec 2018 Recruiting --> Active, not recruiting | Trial completion date: Dec 2017 --> Sep 2018 | Trial primary completion date: Jun 2017 --> Apr 2018